The U.S. delegation to the Codex Committee on Food Hygiene (CCFH)
has recommended returning draft microbiological criteria for Listeria
monocytogenes in ready-to-eat foods to Step 2 in the eight-step Codex
approval process at the CCFH meeting that took place in early November
in New Delhi, India. The United States said it favored a microbiological
criterion that would reject lots of ready-to-eat foods supporting the
growth of L. monocytogenes if the food contains low levels of the
pathogen.
The U.S. said its position "is reflected in the current U.S.
requirement for either absence of L. monocytogenes in 25 grams or 50g of
ready-to-eat foods, [which has] proven highly effective for foods that
support the growth of L. monocytogenes." The draft position noted
that proposed Codex criterion is absence in 125g, an increase in
stringency of 2.5- to 5.0-fold, adding: "The U.S. will be
requesting a more precise estimate of the degree of increased public
health protection that would be realized by moving to this more
stringent criterion."
The U.S. has also opposed including a second microbiological
criterion for foods supporting the growth of L. monocytogenes in which
the levels of the pathogen do not exceed 100 colony forming units per
gram at point of consumption - provided the manufacturer validates that
the product would not exceed that limit at the end of shelf-life.
"The U.S. notes the lack of a practical means for actually
implementing such a criterion," the draft position said, noting it
would have to take into account the degree to which consumers are likely
to make a purchase decision based on a date-label.
The U.S. also plans to insist on language "that recognizes the
validity of national governments establishing criteria for environmental
testing and process control testing where appropriate. These are
important tools for verification of control of L. monocytogenes by
regulatory agencies."
Asked about feedback on the draft position, U.S. delegate Robert
Buchanan said he had received informal comments from European countries,
which do not support it. "There's not a true appreciation that
the [proposed] new standard is more stringent than ours," he said,
promising to educate other countries on the U.S. position.
On other agenda items, the U.S. planned to:
* Oppose an FAO/WHO recommendation to remove Codex restrictions on
use of the lactoperoxidase system for preserving raw milk in milk or
dairy products intended for international trade.
* Recommend advancing to Step 5 a draft code of hygienic practice
for powdered formulas for infants and young children. The U.S. said
further discussion is needed on "the role of cautionary labeling in
promoting health care professional and consumer awareness of the
microbiological hazards associated with powered infant formula and in
informing these groups of control strategies." A representative of
the Infant Formula Council told the meeting that consumers are apt to
interpret the phrase "not sterile" on labels as an indication
of contamination.
* Recommend advancing to Step 5/8 for fast track adoption U.S.-led
draft guidelines for validation of food safety control measures. This
item has been on the CCFH agenda for a decade, but time constraints have
limited debate.
* Recommend advancing into the Codex eight-step approval process a
discussion paper by New Zealand and Sweden on proposed guidelines for
control of Campylobacter and Salmonella in broiler chicken meat
* Recommend advancing to Step 5/8 for fast track adoption an annex
to principles and guidelines for the conduct of microbiological risk
management - guidance on microbiological risk management metrics.
Buchanan said the U.S. is "extremely pleased" with the
progress of the U.S.-led work group, which achieved "an amazing
degree of consensus on a very complex issue".
* Recommend that CCFH give priority to new work on a code of
hygienic practice for fresh fruits and vegetables and - if the agenda
can accommodate two new work items - a code of hygienic practice for
controlling Vibrio species in fish and shellfish.
COPYRIGHT 2007 Informa Economics,
Inc. Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2007, Gale Group. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.